Leveraging the range of scales available from automated synthesisers means the ability to manufacture from milligrams of discovery-based peptides to kilograms for clinical trials
As a company founded on the automation of peptide synthesis, Advanced ChemTech is uniquely qualified to offer versatile custom peptide synthesis services to customers around the world. Leveraging the range of scales available from its range of automated synthesisers Advanced ChemTech is able to manufacture from milligrams of discovery-based peptides right up to kilograms of peptides for clinical trials.
For bulk quantities peptides are manufactured under strict FDA regulated conditions ensuring the highest product quality and consistency.
Drawing upon nearly two decades of experience in peptide manufacturing Advanced ChemTech's team of dedicated scientists are versed in both solid and solution phase peptide synthesis.
Using analytical techniques developed over many years of testing has provided Advanced ChemTech with a uniquely extensive historical product database to draw upon.
Advanced ChemTech is one of the world's largest suppliers of non-natural amino acids.
The company has considerable experience in small to medium scale synthesis of chiral products for use in peptide and combinatorial chemistry as well as expertise in both stereo-selective and stereo-specific synthetic strategies.
All processes are developed with scale-up in mind.
Advanced ChemTech is also a bulk producer of Fmoc, Boc and Cbz protected amino acids.
State-of-the-art manufacturing processes minimise impurities that can diminish yields and the purity of the finished product.
Strict quality assurance and testing standards set Advanced ChemTech apart from other manufacturers as evidenced by the Certificate of Analysis that accompanies every shipment.
All of the solid supports used by Advanced ChemTech are manufactured onsite from their respective monomers using polymerisation techniques perfected to ensure the highest quality resulting in excellent yields and high purity of final peptide products.